Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Multicenter Study of Susceptibility of Aspergillus Species Isolated From Iranian University Hospitals to Seven Antifungal Agents Publisher Pubmed



Badiee P1 ; Boekhout T2, 3 ; Mahmoudabadi AZ4 ; Mohammadi R5 ; Mousavi SAA6 ; Najafzadeh MJ7 ; Soltani J8 ; Hashemi J9 ; Diba K10 ; Ghadimimoghadam A11 ; Salimikhorashad AR12 ; Shokohi T13 ; Shahidi MA1 ; Ghasemi F1 Show All Authors
Authors
  1. Badiee P1
  2. Boekhout T2, 3
  3. Mahmoudabadi AZ4
  4. Mohammadi R5
  5. Mousavi SAA6
  6. Najafzadeh MJ7
  7. Soltani J8
  8. Hashemi J9
  9. Diba K10
  10. Ghadimimoghadam A11
  11. Salimikhorashad AR12
  12. Shokohi T13
  13. Shahidi MA1
  14. Ghasemi F1
  15. Jafarian H1
Show Affiliations
Authors Affiliations
  1. 1. Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. 2. Westerdijk Fungal Biodiversity Institute, Utrecht, Netherlands
  3. 3. Institute for Biodiversity and Ecosystem Dynamics, IBED, University of Amsterdam, Amsterdam, Netherlands
  4. 4. Infectious and Tropical Diseases Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  5. 5. Department of Medical Parasitology and Mycology, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Medical Parasitology and Mycology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  7. 7. Department of Medical Parasitology and Mycology, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Department of Pediatrics, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran
  9. 9. Medical Mycology Department, School of Public Health Research, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Cellular and Molecular Research Center, Urmia University of Medical Sciences, Urmia, Iran
  11. 11. Department of Pediatrics Infectious Disease, Emmam Sajjad Hospital, Yasuj University of Medical Sciences, Yasuj, Iran
  12. 12. Department of Parasitology and Mycology, School of Medicine, Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
  13. 13. Department of Medical Mycology, School of Medicine, Invasive Fungi Research Centre (IFRC), Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran

Source: Microbiology Spectrum Published:2022


Abstract

Aspergillus species are a major cause of life-threatening invasive infections and noninvasive diseases. This study seeks to investigate the frequency of Aspergillus species among Iranian patients and their susceptibility to seven antifungals. In a cross-sectional study, 233 Aspergillus isolates were collected from 11 university hospitals in Iran between 2018 and 2021. Aspergillus isolates were identified based on colony morphology, microscopic characteristics, PCR-restriction fragment length polymorphism (RFLP), and sequencing of the beta-tubulin gene. The CLSI M38-A2 reference methodology was used for antifungal susceptibility testing of amphotericin B, voriconazole, posaconazole, itraconazole, luliconazole, isavuconazole, and caspofungin. Members of Aspergillus section Flavi (117/233, 50.2%), Aspergillus section Nigri (77/233, 33.1%), Aspergillus section Fumigati (21/233, 9%), Aspergillus section Terrei (14/233, 6%), Aspergillus pseudodeflectus (2/233, 0.85%), and Aspergillus melleus (2/233, 0.85%) were isolated from the samples. The lowest 0.25 MIC90 values for all isolates tested were for luliconazole (0.016 mg/mL) and isavuconazole (0.250 mg/mL), and the highest value was observed for itraconazole ($ 8mg/mL). The 90% minimum effective concentration (MEC90) value for caspofungin was 0.125 mg/mL. MIC90 values for voriconazole, amphotericin B, and posaconazole were 1, 2, and 2 mg/mL, respectively. The non-wild-type species were presented for amphotericin B (3%), voriconazole (1.3%), posaconazole (2.6%), luliconazole (1.3%), isavuconazole (1.7%), and caspofungin (4.7%). Positive correlations in the MIC values of azole antifungals were observed, and using one azole increases the MIC value rates of other ones. None of the species were pan-azole resistant. Species of Aspergillus section Flavi were the most common Aspergillus species isolated from Iranian samples. Luliconazole, caspofungin, and isavuconazole present the most effective antifungal agents for treatment of infection due to Aspergillus species. Susceptibility tests should be performed frequently in each region for the best management of patients. IMPORTANCE Aspergillus species are the leading cause of invasive aspergillosis in immunocompromised hosts. The susceptibility of Aspergillus species to antifungal agents might be different. Azole-resistant species have emerged worldwide. Performing susceptibility testing in each region can help in the best management of patients. Here, we show the epidemiology and distribution of Aspergillus species in Iran and their susceptibility patterns for seven antifungal agents. The significant points of the present study are that species of Aspergillus section Flavi are the most prevalent Aspergillus species isolated from 11 university hospitals. Luliconazole, caspofungin, and isavuconazole were effective antifungal agents against all Aspergillus species. Copyright © 2022 Badiee et al.
Other Related Docs
31. Candidemia in Children Caused by Uncommon Species of Candida, Archives of Pediatric Infectious Diseases (2018)